Analystreport

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) had its price target raised by analysts at HC Wainwright from $45.00 to $58.00. They now have a "buy" rating on the stock.

Mirum Pharmaceuticals, Inc. - common stock  (MIRM) 
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm Check Earnings Report